Search results
Showing results for
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
Your Rights
Your rights under the General Data Protection Regulation
10th NIHR OTS Musculoskeletal Trauma Trials Annual Meeting
This event is run by the Orthopaedic Trauma Society and the National Institute for Health and Care Research with support from Clockwork Medical. To register, please click on the link below.
Cemented or Uncemented Hemiarthroplasty for Intracapsular Hip Fracture
Paper published in The New England Journal of Medicine.
Bristol Oxford Surgical Trials Intervention Course (BOSTiC)
New dates are to be announced soon for BOSTiC 2022. Please email situ@ndorms.ox.ac.uk to add your name to the waiting list and be informed as soon as delegates are able to register.
Read our latest study
Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)
octova
Please visit OCTOVA website
Bristol and Oxford Surgical Trials Intervention Course (BOSTiC) 2020
The Oxford and Bristol Surgical Trials Units will be holding a 3 day surgical research training event on surgical trials for foundation, core and specialist trainees of all surgical specialities.